• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India.急性慢性肝衰竭(ACLF)的临床特征与预后标志物:来自印度东部的单中心经验
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1017-1024. doi: 10.1016/j.jceh.2023.06.010. Epub 2023 Jul 1.
2
Clinical Profile, Short-term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C OF Scores in Acute-on-chronic Liver Failure Patients: A Prospective Observational Study.慢性肝病急性肝衰竭患者的临床特征、CLIF-C ACLF评分及连续CLIF-C OF评分的短期预后准确性:一项前瞻性观察研究
Indian J Crit Care Med. 2024 Feb;28(2):126-133. doi: 10.5005/jp-journals-10071-24640.
3
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.慢性肝衰竭-序贯器官衰竭评估在定义慢加急性肝衰竭和预测预后方面优于亚太肝病研究学会的标准。
World J Gastroenterol. 2014 Oct 28;20(40):14934-41. doi: 10.3748/wjg.v20.i40.14934.
4
Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome.酒精相关的慢加急性肝衰竭——各种预后评分对结局预测的比较
Indian J Gastroenterol. 2018 Jan;37(1):50-57. doi: 10.1007/s12664-018-0827-z. Epub 2018 Feb 23.
5
Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF.预测乙型肝炎病毒相关慢加急性肝衰竭患者短期死亡率的预后评分验证:CLIF-C OF优于MELD、CLIF SOFA和CLIF-C ACLF。
Medicine (Baltimore). 2017 Apr;96(17):e6802. doi: 10.1097/MD.0000000000006802.
6
Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.肝内和肝外损伤对慢加急性肝衰竭预后的影响。
J Clin Exp Hepatol. 2017 Mar;7(1):9-15. doi: 10.1016/j.jceh.2016.10.006. Epub 2016 Oct 29.
7
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
8
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.并发症是乙型肝炎病毒相关慢加急性肝衰竭患者死亡的主要危险因素:亚太地区的一项多国家研究。
Hepatol Int. 2019 Nov;13(6):695-705. doi: 10.1007/s12072-019-09992-x. Epub 2019 Oct 24.
9
Comparing CLIF-C ACLF, CLIF-C ACLF, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience.单中心重症监护病房经验:比较慢性肝衰竭急性发作患者的CLIF-C ACLF、CLIF-C ACLF和CLIF-C ACLF-D预后评分
J Pers Med. 2021 Jan 29;11(2):79. doi: 10.3390/jpm11020079.
10
CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review.CLIF-SOFA和CLIF-C评分对慢性肝衰竭急性发作和肝硬化急性失代偿的预后评估:一项系统评价。
World J Hepatol. 2022 Dec 27;14(12):2025-2043. doi: 10.4254/wjh.v14.i12.2025.

引用本文的文献

1
Clinical Profile, Short-term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C OF Scores in Acute-on-chronic Liver Failure Patients: A Prospective Observational Study.慢性肝病急性肝衰竭患者的临床特征、CLIF-C ACLF评分及连续CLIF-C OF评分的短期预后准确性:一项前瞻性观察研究
Indian J Crit Care Med. 2024 Feb;28(2):126-133. doi: 10.5005/jp-journals-10071-24640.

本文引用的文献

1
Acute-on-Chronic Liver Failure.慢加急性肝衰竭
N Engl J Med. 2020 May 28;382(22):2137-2145. doi: 10.1056/NEJMra1914900.
2
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF.失代偿期肝硬化和慢加急性肝衰竭患者的循环DNA血浆水平与预后相关,但与凝血激活无关。
JHEP Rep. 2019 Jun 28;1(3):179-187. doi: 10.1016/j.jhepr.2019.06.002. eCollection 2019 Sep.
3
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.急性肝衰竭合并慢性肝病:亚太肝病学会(APASL)的共识推荐意见:更新版。
Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6.
4
Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.验证 CLIF-C ACLF 评分是否能够确定慢性加急性肝衰竭患者接受强化治疗支持的无效阈值。
Crit Care. 2018 Oct 10;22(1):254. doi: 10.1186/s13054-018-2156-0.
5
Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care.入住重症监护病房的严重脓毒症患者的游离循环DNA水平可预测28天死亡率。
PLoS One. 2014 Jun 23;9(6):e100514. doi: 10.1371/journal.pone.0100514. eCollection 2014.
6
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.开发和验证一种预后评分系统,以预测慢加急性肝衰竭患者的死亡率。
J Hepatol. 2014 Nov;61(5):1038-47. doi: 10.1016/j.jhep.2014.06.012. Epub 2014 Jun 17.
7
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.急性慢性肝衰竭是一种独特的综合征,发生在肝硬化急性失代偿的患者中。
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9. doi: 10.1053/j.gastro.2013.02.042. Epub 2013 Mar 6.
8
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis.严重脓毒症患者游离DNA的预后效用及特征分析
Crit Care. 2012 Aug 13;16(4):R151. doi: 10.1186/cc11466.
9
Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis.中性粒细胞衍生的循环游离DNA(cf-DNA/NETs):创伤后炎症二次打击和脓毒症发生的潜在预后标志物。
Shock. 2008 Oct;30(4):352-8. doi: 10.1097/SHK.0b013e31816a6bb1.
10
Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients.血浆DNA浓度作为危重症患者死亡率和脓毒症的预测指标
Crit Care. 2006;10(2):R60. doi: 10.1186/cc4894.

急性慢性肝衰竭(ACLF)的临床特征与预后标志物:来自印度东部的单中心经验

Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India.

作者信息

Halder Prasenjit, Roy Susree, Banerjee Soma, Mandal Syamsundar, Das Kausik, Chowdhury Abhijit, Mahiuddin Ahammed Sk

机构信息

Department of Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata.

Center for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata.

出版信息

J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1017-1024. doi: 10.1016/j.jceh.2023.06.010. Epub 2023 Jul 1.

DOI:10.1016/j.jceh.2023.06.010
PMID:37975045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10643518/
Abstract

AIM

The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF.

METHODS

In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and compared with the CLIF-C ACLF score.

RESULTS

The median age of 132 consecutive ACLF patients was 40 years. The most common acute insult were sepsis (30.3%) and alcohol (22%). While alcohol (35.6%) and chronic HBV (14.3%) were the most common etiologies of cirrhosis. The overall mortality was 45.5% and 71.2% at 28 days and 90 days, respectively. Multiple regression analysis using the Cox proportional hazard model showed that heart rate (HR 1.06, 95% CI 1.04-1.08  = 0.001), lung failure (HR 2.82, 95% CI 1.24-6.44,  = 0.02), and cell-free DNA (HR 2.70, 95% CI 1.17-6.24,  = 0.02) were independent predictors of mortality When Cf DNA was used to predict 28-day mortality, Cf DNA was found to have a higher AUC (AUROC 0.84, 95% CI 0.70-0.98,  = 0.001) than the CLIF-C-ACLF score (AUROC 0.81, 95% 0.66-0.97,  = 0.003). However, when 90-day mortality was compared, CLIF-C-ACLF score had a higher area under the curve (AUROC 0.93, 95% CI 0.83-1.00,  = 0.0001) than Cf DNA (AUROC 0.89, 95% CI 0.77-1.00,  = 0.0001).

CONCLUSIONS

Alcohol and sepsis remain the most common causes of acute insult. Cf DNA is a better predictor of 28-day mortality, whereas CLIF-C ACLF is more accurate to predict 90-day mortality.

摘要

目的

本研究旨在探讨慢加急性肝衰竭(ACLF)的临床特征,并确定游离DNA(Cf DNA)作为ACLF预后的预测指标。

方法

在这项前瞻性研究中,纳入了符合欧洲肝脏研究学会(EASL)标准的患者。对30例患者进行了Cf DNA检测,并与CLIF-C ACLF评分进行比较。

结果

132例连续性ACLF患者的中位年龄为40岁。最常见的急性诱因是脓毒症(30.3%)和酒精(22%)。而酒精(35.6%)和慢性乙型肝炎病毒(HBV)感染(14.3%)是肝硬化最常见的病因。28天和90天的总死亡率分别为45.5%和71.2%。使用Cox比例风险模型进行的多元回归分析显示,心率(HR 1.06,95%CI 1.04 - 1.08,P = 0.001)、肺功能衰竭(HR 2.82,95%CI 1.24 - 6.44,P = 0.02)和游离DNA(HR 2.70,95%CI 1.17 - 6.24,P = 0.02)是死亡率的独立预测因素。当使用Cf DNA预测28天死亡率时,发现Cf DNA的曲线下面积(AUROC 0.84,95%CI 0.70 - 0.98,P = 0.001)高于CLIF-C-ACLF评分(AUROC 0.81,95%CI 0.66 - 0.97,P = 0.003)。然而,在比较90天死亡率时,CLIF-C-ACLF评分的曲线下面积(AUROC 0.9